The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer.
 
Darren Lee
No Relationships to Disclose
 
Bailey Nelson
No Relationships to Disclose
 
Shesh Rai
No Relationships to Disclose
 
Jayesh Rai
No Relationships to Disclose
 
Kyle Wang
No Relationships to Disclose
 
Davendra Sohal
Consulting or Advisory Role - AADi; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Regeneron; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma
 
Olugbenga Olanrele Olowokure
No Relationships to Disclose
 
Adam Rojan
Research Funding - Isofol Medical (Inst); Merck (Inst)
 
Sameer H. Patel
No Relationships to Disclose
 
Gregory Wilson
No Relationships to Disclose
 
Syed A. Ahmad
Speakers' Bureau - Abbvie
 
Jordan Kharofa
No Relationships to Disclose